期刊文献+

New triazole derivatives containing substituted 1,2,3-triazole side chains:Design,synthesis and antifungal activity

New triazole derivatives containing substituted 1,2,3-triazole side chains:Design,synthesis and antifungal activity
原文传递
导出
摘要 In order to discover new generation of triazole antifungal agents,a series of novel antifungal triazoles were designed and synthesized by structural simplification of our previously identified triazolepiperdine-heterocycle lead compounds.Several target compounds showed good antifungal activity with a broad spectrum.In particular,compound 71 was highly active against Candida albicans and Candida glabrata.Moreover,compound 71 showed potent in vivo antifungal efficacy in the Caenorhabditis elegans-C.albicans infection model. In order to discover new generation of triazole antifungal agents,a series of novel antifungal triazoles were designed and synthesized by structural simplification of our previously identified triazolepiperdine-heterocycle lead compounds.Several target compounds showed good antifungal activity with a broad spectrum.In particular,compound 71 was highly active against Candida albicans and Candida glabrata.Moreover,compound 71 showed potent in vivo antifungal efficacy in the Caenorhabditis elegans-C.albicans infection model.
出处 《Chinese Chemical Letters》 SCIE CAS CSCD 2017年第4期913-918,共6页 中国化学快报(英文版)
基金 supported by the National Natural Science Foundation of China(Nos.81573283,21502224) the 863 Hi-Tech Program of China(No.2014AA020525) the Shanghai"ShuGuang"Project(No.14SG33)
关键词 Triazole derivatives Antifungal activities Click reaction Molecular docking CYP51 Triazole derivatives Antifungal activities Click reaction Molecular docking CYP51
  • 相关文献

参考文献1

二级参考文献25

  • 1M.A. Pfaller, D.J. Diekema, Epidemiology of invasive candidiasis: a persistent public health problem, Clin. Microbiol. Rev. 20 (200?) 133-163.
  • 2L. Ostrosky-Zeichner, A. Casadevall, J.N. Galgiani, et al. An insight into the antifungal pipeline: selected new molecules and beyond, Nat. Rev. Drug Discov. 9 (2010) 719-727.
  • 3S.K. Fridkin, W.R. Jarvis, Epidemiology of nosocomial fungal infections, Clin. Microbiol. Rev. 9 (1996)499-511.
  • 4H.A. Gallis, R.H. Drew, W.W. Pickard, Amphotericin B: 30 years of clinical experi- ence, Rev. Infect. Dis. 12 (1990) 308-329.
  • 5D.J. Sheehan, C.A. Hitchcock, C.M. Sibley, Current and emerging azole antifungal agents, Clin. Microbiol. Rev. 12 (1999) 40-79.
  • 6D.W. Denning, Echinocandins: a new class of antifungal, J. Antimicrob. Che- mother. 49 (2002) 889-891.
  • 7I.A. Casalinuovo, P. Di Francesco, E. Garaci, Fluconazole resistance in Candida albicans: a review of mechanisms, Eur. Rev. Med. Pharmacol. Sci. 8 (2004) 69-77.
  • 8C. Sheng, W. Zhang, New lead structures in antifungal drug discovery, Curr. Med. Chem. 18 (2011) 733-766.
  • 9W. Wang, G. Dung, J. Gu, et al. Structure-activity relationships of tetrahydro- carbazole derivatives as antifungal lead compounds, Med. Chem. Commun. 4 (2013) 353-362.
  • 10X. Che, C. Sheng, W. Wang, et al. New azoles with potent antifungal activity: design, synthesis and molecular docking, Eur. J. Med. Chem. 44 (2009) 4218- 4226.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部